著名医疗数据和分析服务公司艾昆纬(IQV)今日盘中大涨6.16%,引发市场广泛关注。从公司公布的2024年第四季度财报数据来看,推动股价上涨的主要原因是该公司最新一季度业绩表现优于华尔街预期。
财报显示,艾昆纬第四季度实现调整后每股收益3.12美元,略高于分析师一致预期的3.11美元。营收方面,公司第四季度收入为39.58亿美元,同样超过了39.35亿美元的市场预期。
数据显示,公司技术和分析解决方案部门在过去一季度保持强劲表现,是拉动业绩超预期的主要推手。这一部门主要为制药和消费者健康公司提供信息和技术服务。随着过去两年药物批准数量增加,推动制药客户的商业支出回升,有力带动了该部门收入的增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.